BBBT (Black Bird Biotech) Accounts Payable: $0.07 Mil (As of Sep. 2023)

Author: Vera Yuan Vera Yuan
Vera Yuan
Vera Yuan
Director of Data and Quant Analytics at GuruFocus
Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Reviewed by: Charlie Tian Charlie Tian
Charlie Tian
Charlie Tian
Founder & CEO of GuruFocus
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.

What is Black Bird Biotech Accounts Payable?

Black Bird Biotech BBBT -99.00% Accounts Payable is $0.07 Mil as of Sep. 2023.

Black Bird Biotech's Accounts Payable for the quarter that ended in Sep. 2023 was $0.07 Mil.

Black Bird Biotech's quarterly Accounts Payable increased from Mar. 2023 ($0.06 Mil) to Jun. 2023 ($0.06 Mil) and increased from Jun. 2023 ($0.06 Mil) to Sep. 2023 ($0.07 Mil).

Black Bird Biotech's annual Accounts Payable declined from Dec. 2020 ($0.05 Mil) to Dec. 2021 ($0.04 Mil) but then increased from Dec. 2021 ($0.04 Mil) to Dec. 2022 ($0.10 Mil).

Black Bird Biotech Accounts Payable Related Terms

Black Bird Biotech Accounts Payable Historical Data

* Premium members only.

The historical data trend for Black Bird Biotech's Accounts Payable can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Black Bird Biotech Accounts Payable Chart

Black Bird Biotech Annual Data
Trend Dec13 Dec14 Dec15 Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22
Accounts Payable
Get a 7-Day Free Trial Premium Member Only Premium Member Only 0.02 0.27 0.05 0.04 0.10

Black Bird Biotech Quarterly Data
Dec18 Mar19 Jun19 Sep19 Dec19 Mar20 Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23
Accounts Payable Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 0.06 0.10 0.06 0.06 0.07

Black Bird Biotech Accounts Payable Calculation

Accounts Payable represents any money that a company owes its suppliers for goods and services purchased on credit and is expected to pay within the next year or operating cycle.

Frequently Asked Questions Learn more about Accounts Payable →
What does a Accounts Payable of $0.07 Mil mean?
Black Bird Biotech (BBBT) has a Accounts Payable of $0.07 Mil as of Sep. 2023. Accounts Payable is any money that a company owes for goods and services purchased on credit and is expected to pay within the next year. View historical data on Black Bird Biotech and its competitors.
Is Black Bird Biotech's Accounts Payable too high?
Black Bird Biotech's current Accounts Payable is $0.07 Mil.
How does Black Bird Biotech's Accounts Payable compare to BLMS and INLB?
Black Bird Biotech's Accounts Payable of $0.07 Mil can be compared against companies in the Drug Manufacturers industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Accounts Payable for a Drug Manufacturers company?
A good Accounts Payable depends on the Drug Manufacturers industry context. However, Accounts Payable should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Accounts Payable mean?
A high Accounts Payable can signal that a stock is expensive relative to its fundamentals. Accounts Payable is any money that a company owes for goods and services purchased on credit and is expected to pay within the next year. View historical data on Black Bird Biotech and its competitors. Black Bird Biotech's current Accounts Payable is $0.07 Mil. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Black Bird Biotech stock overvalued right now?
Black Bird Biotech (BBBT) has a current Accounts Payable of $0.07 Mil. The current Accounts Payable is $0.07 Mil. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Accounts Payable calculated?
Accounts Payable is calculated from a company's financial statements. For Black Bird Biotech (BBBT), the current Accounts Payable is $0.07 Mil as of Sep. 2023. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Black Bird Biotech Business Description

Address 2801 E Camelback Road, Suite 200, Phoenix, AZ, USA, 85016
Black Bird Biotech Inc is a licensed grower of industrial hemp under the Montana Hemp Pilot Program. In addition, it is the distributor in the U. S. and Canada for MiteXstream, an EPA-registered plant-based biopesticide effective in the eradication of spider mites, a pest that destroys crops, especially cannabis, hops, coffee, and house plants, as well as molds and mildew. Its products include MiteXstream Biopesticide, Grizzly Creek Naturals, and Black Bird American Hemp.